Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Celiac Disease Complicated by a Rare, Ulcerative Duodenal Adenocarcinoma

Nada Boutrid, Hakim Rahmoune*, Mounira Amrane, Abderraouf Bataiche, Naouel Lemdaoui

LMCVGN Research Laboratory; Setif-1 University, Algeria

Abstract: Celiac Disease (CD) is an autoimmune condition that is well-known to be associated with increased risk of malignancies, specifically gastro-intestinal neoplasms. We report a case of a young male patient with CD presenting with an ulcerative duodenal adenocarcinoma, successfully operated by cephalic pancreaticoduodenectomy.

Keywords: celiac disease, histopathology, small bowel adenocarcinoma

Received June 03, 2020; Revised June 20, 2020; Accepted June 25, 2020

Citation: Nada Boutrid, Hakim Rahmoune, Mounira Amrane, Abderraouf Bataiche, Naouel Lemdaoui, Celiac Disease Complicated by a Rare, Ulcerative Duodenal Adenocarcinoma. International Journal of Celiac Disease, 8 (2). 54-55. January 2020. doi:10.12691/ijcd-8-2-3

1. Introduction

Celiac Disease (CD) is an emerging autoimmune disease and is well known to predispose to various malignancies. There is an important clinical heterogeneity in celiac patients, strengthening the need of screening for such neoplastic complications. [1,2,3]

We report a case of a young male patient with CD presenting with an ulcerative duodenal adenocarcinoma, successfully operated by cephalic pancreatico-duodenectomy.

2. Case Description

A 34 year old male celiac patient presented to the emergencies for acute abdominal (epigastric) pain.

A thorough investigation was ordered: ultrasounds retrieved a small bowel mass while abdominal CT and the abdominal MRi confirmed the duodenum localization of the tumor.

Upper gastrointestinal endoscopy found an ulcerative, semi-obstructive mass of third duodenum, and subsequent biopsies and pathology highlighted an adenocarcinoma.

The patient could benefited a curative pancreaticoduodenectomy with good post-operative results.

3. Discussion

Growing data, with meta-analyses, systematic reviews and population-based studies, confirm that patients with diagnosed CD are at increased risk of malignancy and mortality [4,5].

In fact, people with CD have a high risk of lymphoproliferative malignancies and digestive neoplasms. The peculiar enteropathy-associated T cell lymphoma (EATL) mght also occur, particularly in patients with refractory CD [1,6].

Thus, a 2015 meta-analysis found that CD was associated with increased risk of all malignancies as well as gastro-intestinal (GI) malignancies, including esophageal neoplasm and small bowel carcinoma: the pooled Odds Ratio (OR) for risk of all malignancies was 1.25 in CD population, and the OR of GI malignancy was as high as 1.60.

Specifically, patients with CD have a great risk of esophageal cancer (OR = 3.72) and small bowel adenocarcinoma (OR = 14.41) [7].

This latter small bowel adenocarcinoma (SBA) is a rare neoplasm, appearing as a sporadic form or associated with a number of predisposing conditions such as immune-mediated intestinal disorders, e.g CD [8].

Celiac-related SBA cases are characterized by a younger age of onset, a higher prevalence in female gender and a better overall survival compared to sporadic, Crohn- and hereditary syndrome-related SBA [8].

A 2020-published Cohort Study of 347 Patients with newly diagnosed or recurrent SBA at 74 French centres found that the prevalence of a predisposing CD was as high as 1.7% [9].

Among these SBAs, primary carcinoma of the duodenum (like in our patient) is considered as rare : duodenal adenocarcinoma accounts for less than 0.5% of all gastrointestinal cancers and 30-45% of small intestinal cancers [10].

The role of celiac patients follow-up needs more evidence than actually available.

A recently published systematic review of 31 eligible studies found that persisting symptoms were more frequently associated with persisting villous atrophy and this persisting villous atrophy might be a risk factor of lymphomas (although a lot of symptom-free patients had persisting villous atrophy, and many symptomatic patients achieved a mucosal recovery) [11].

Unfortunately, a concomitant celiac serology for this patient (to uncover a causative refractory sprue, for example) could not be obtained.

Imaging is also crucial for such complicated disease. Particularly, magnetic resonance imaging (MRI) is an extremely useful tool for demonstrating duodenal lesions as well as anatomic relationships with adjacent intra-abdominal organs; and is considered as paramount in enabling to establish promptly a correct diagnosis and to plan appropriate surgical procedures [12].

Evidently, surgery is paramount in this condition. Surgical resection in order to achieve clear operative margins is the only available option for cure of this disease; either through pancreaticoduodenectomy or through pancreas-sparing duodenal segmental resection [10].

Our patient benefited a curative surgery by cephalic pancreaticoduodenectomy with good postoperative results.

Finally, in such SBA-resected tumors, the main prognostic factors for overall survival were grade and tumor stage [9].

4. Conclusion

Digestive neoplasms, like small bowel carcinoma, are a rare but real risk in celiac patients.

A long-life gluten free diet and a thourough follow-up are imperative; and a curative surgical approach is highly recommended.

Acknowledgements

N. Boutrid, H. Rahmoune, M. Amrane (from LMCVGN laboratory) and N. Lemdaoui are supported by the Directorate General for Scientific Research and Technological Development (DGRSDT), MESRS, Algeria.

The sponsor had no involvement in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript.

References

[1]   | Spijkerman M, Tan IL, Kolkman JJ, Withoff S, Wijmenga C, Visschedijk MC, Weersma RK. A large variety of clinical features and concomitant disorders in celiac disease–A cohort study in the Netherlands. Digestive and Liver Disease. 2016 May 1; 48(5): 499-505.
[2]   | Freeman HJ. Celiac disease and selected long-term health issues. Maturitas. 2012 Nov 1; 73(3): 206-11.
[3]   | Rahmoune H, Boutrid N, Amrane M, Ouhida S, Abdellouche D, Bioud B. Celiac Disease & Lymphoproliferative Malignancy at Adulthood. International Journal of Celiac Disease. 2018; 6(2): 47-8.
[4]   | Ludvigsson JF. Mortality and malignancy in celiac disease. Gastrointestinal Endoscopy Clinics. 2012 Oct 1; 22(4): 705-22.
[5]   | Rubio-Tapia A, Ludvigsson JF, Brantner TL, Rajkumar SV, Landgren O, Murray JA. Increased mortality among men aged 50 years old or above with elevated IgA anti-transglutaminase antibodies: NHANES III. BMC gastroenterology. 2016 Dec; 16(1): 136.
[6]   | Marchi E, O’Connor OA. The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management. CA: A Cancer Journal for Clinicians. 2020 Jan;70(1):47-70.
[7]   | Han Y, Chen W, Li P, Ye J. Association between coeliac disease and risk of any malignancy and gastrointestinal malignancy: a meta-analysis. Medicine. 2015 Sep; 94(38).
[8]   | Caio G, Volta U, Ursini F, Manfredini R, De Giorgio R. Small bowel adenocarcinoma as a complication of celiac disease: clinical and diagnostic features. BMC Gastroenterol. 2019; 19(1):45.
[9]   | Aparicio T, Henriques J, Manfredi S, et al. Small bowel adenocarcinoma: Results from a nationwide prospective ARCAD-NADEGE cohort study of 347 patients [published online ahead of print, 2020 Jan 7]. Int J Cancer. 2020.
[10]   | Pisello F, Geraci G, Li Volsi F, Stassi F, Modica G, Sciumè C. Duodenal Signet Ring Cell Carcinoma in a Celiac Patient. Case Rep Gastroenterol. 2009; 3(1):49‐55.
[11]   | Szakács Z, Gede N, Gyöngyi Z, Solymár M, Csupor D, Erőss B, Vincze Á, Mikó A, Vasas A, Szapáry L, Dobszai D. A call for research on the prognostic role of follow-up histology in celiac disease: A systematic review. Frontiers in Physiology. 2019; 10.
[12]   | Dusunceli Atman E, Erden A, Ustuner E, Uzun C, Bektas M. MRI Findings of Intrinsic and Extrinsic Duodenal Abnormalities and Variations. Korean J Radiol. 2015; 16(6): 1240‐1252.